Advanced search
Publication Cover
Critical Reviews in Microbiology Volume 44, 2018 - Issue 1
Submit an article Journal homepage
575
Views
6
CrossRef citations to date
0
Altmetric
Review Article

The next chapter for group B meningococcal vaccines

N. Y. WangSchool of Medicine, Monash University, Melbourne, Australia; ;Department of Paediatrics, Oxford Vaccine Group, Oxford, UK; Correspondence[email protected]
View further author information
&
A. J. PollardDepartment of Paediatrics, Oxford Vaccine Group, Oxford, UK; ;NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UKView further author information
Pages 95-111 | Received 28 Nov 2016, Accepted 19 Apr 2017, Published online: 30 May 2017

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Jamie Findlow, Ray Borrow, David S. Stephens, Paul Liberator, Annaliesa S. Anderson, Paul Balmer & Luis Jodar. (2022) Correlates of protection for meningococcal surface protein vaccines: current approaches for the determination of breadth of coverage. Expert Review of Vaccines 21:6, pages 753-769.
Read now
Jamie Findlow, Jay Lucidarme, Muhamed-Kheir Taha, Cynthia Burman & Paul Balmer. (2022) Correlates of protection for meningococcal surface protein vaccines: lessons from the past. Expert Review of Vaccines 21:6, pages 739-751.
Read now
Marco Aurelio P. Safadi, Federico Martinón-Torres, Lidia Serra, Cynthia Burman & Jessica Presa. (2021) Translating meningococcal serogroup B vaccines for healthcare professionals. Expert Review of Vaccines 20:4, pages 401-414.
Read now
Irene Rivero-Calle, Peter Francis Raguindin, Jose Gómez-Rial, Carmen Rodriguez-Tenreiro & Federico Martinón-Torres. (2019) Meningococcal Group B Vaccine For The Prevention Of Invasive Meningococcal Disease Caused By Neisseria meningitidis Serogroup B. Infection and Drug Resistance 12, pages 3169-3188.
Read now
Rouba Shaker, Danielle Fayad & Ghassan Dbaibo. (2018) Challenges and opportunities for meningococcal vaccination in the developing world. Human Vaccines & Immunotherapeutics 14:5, pages 1084-1097.
Read now
Helen Petousis-Harris. (2018) Impact of meningococcal group B OMV vaccines, beyond their brief. Human Vaccines & Immunotherapeutics 14:5, pages 1058-1063.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.